ERIC DENNY: Open Payments
NPI 1316436082 · MORRIS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$250 in 14 payments from 7 companies in 2025. Trend: 2023 $1,287 · 2024 $791 · 2025 $250
Food & beverage: $250
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $65 |
| Collegium Pharmaceutical, Inc. | 3 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Neurocrine BioSciences, Inc. | 2 | $35 |
| Almatica Pharma LLC | 2 | $28 |
| Supernus Pharmaceuticals, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: VRAYLAR, Jornay PM, CAPLYTA, INGREZZA, LOREEV XR, Qelbree, REXULTI.
Industry payments across IL — which companies pay providers there.
